Using specific antibody markers and double-label immunofluorescence microscopy, we have followed the fate of progenitor cells in the sympathoadrenal (SA) sublineage of the neural crest in developing rat embryos. Such progenitors are first recognizable in the primordial sympathetic ganglia at embryonic day 11.5 (E 11.5), when they express tyrosine hydroxylase. At this stage, the progenitors also coexpress In vitro, most 82+ cells fail to differentiate into chromaffin cells in response to glucocorticoid. Instead, they continue to extend neurites and then die. Taken together, these data imply that the SA 1 _, 82 transition correlates with a loss of competence to respond to an inducer of chromaffin differentiation. Thus, the development of SA derivatives is controlled both by environmental signals and by changes in the ability of differentiating cells to respond to such signals. Received Jan. 25, 1991; revised May I, 1991; accepted June 11, 1991. We are grateful to Joan Roach for assistance with histology and immunofiuorescence, to Shelly Diamond for help with cell sorting, and to Li-Ching Lo for the preparation of anti-SCG 10 antibodies. We also thank Dr. Jane Dodd (Columbia University, New York) for the generous gift of monoclonal antibody B2 and for helpful suggestions. We thank members of the Anderson laboratory for helpful discussions.
An important problem in developmental neurobiology concerns the mechanism of diversification of the cell types that derive from the neural crest (Le Douarin, 1982) . The dissection of this process has been aided by the use of monoclonal antibodies, which have proven useful tools for the study of neural development (Mirsky, 1982; Reichardt, 1984) . Such antibodies can provide molecular markers of differentiation and can reveal important differences between cells that are otherwise indistinguishable. The preceding article describes the generation and characterization of a novel set of monoclonal antibodies (SAl-5) that, in the postnatal rat, specifically label adrenal chromaffin cells, the major endocrine derivative of the neural crest. These antibodies provide a set of reagents that can be used to identify chromaffin cells and their precursors in developing embryos.
Studies of postnatal (Unsicker et al., 1978; Doupe et al., 19 8 5a, b) and of embryonic chromaffin cells (Anderson and Axel, 1986; Seidl and Unsicker, 1989a,b) have suggested that these adrenal medullary cells derive from a progenitor whose alternate fate is to become a sympathetic neuron. However, it has been difficult to establish whether this lineage relationship holds in vivo. To address this issue, we have examined in sections of developing rat embryos the pattern of expression of the chromaffin-specific sympathoadrenal (SA) antigens in relationship to that of neuron-specific markers. Neuronal markers in this lineage include intracellular proteins such as neurofilament 68 kDa (NF68) (Cochard and Paulin, 1984) and SCG 10 (Anderson and Axel, 1985; Stein et al., l 988b) , as well as cell surface antigens such as B2 (Anderson and Axel, 1986; Anderson, 1988) . Because several of these markers are sequentially expressed in an overlapping manner, the developmental segregation of sympathetic neurons and chromaffin cells from their precursor (s) can be traced in situ.
We found that SAl + cells within the sympathetic ganglion primordium initially coexpress SCG l 0 and tyrosine hydroxylase (TH), suggesting that they have the potential to become either sympathetic neurons or chromaffin cells. Subsequently, SA 1 immunoreactivity is lost and B2 immunoreactivity appears in these sympathetic neuroblasts. By contrast, this antigenic switch does not occur for most of the developing adrenal medullary population. Experiments in vitro suggest that the SA l _, B2 switch correlates with a loss of competence to respond to glucocorticoids, and commitment to the neuronal pathway of differentiation. SA-1 SCG10 Figure I . Initial expression of SA I occurs in developing sympathetic ganglia. Sections are through sympathetic ganglion primordia, at E 11.5. The same section was doubly labeled with SAi (A) and TH (B). The same section was doubly labeled with SAi (C) and polyclonal anti-SCGIO (D). Arrows indicate individual doubly labeled cells. E and F, Higher-magnification view illustrating two process-bearing cell bodies (arrows) doubly labeled by SA I (E) and SCG l O (F). Arrowheads indicate the process from one cell, which is also doubly labeled. Asterisk in C and D indicates autoftuorescent blood cells in the dorsal aorta. The specific staining patterns illustrated were not observed in controls lacking primary. antibody. Scale bars, 33 µm.
Materials and Methods
Immunocytochemistry. Staged embryos were fixed in 4% paraformaldehyde, embedded, and sectioned in a cryostat as described previously (Carnahan and Patterson, 199 la) . Double labeling was performed using an SA 1 ascites fluid diluted l :2000, together with undiluted B2 hybridoma supernatant (a gift from J. Dodd, Columbia University), polyclonal rabbit anti-TH diluted 1:250 (Eugene Tech Inc., Allendale, NJ), or polyclonal rabbit anti-SCG 10 diluted l :250 (Stein et al., l 988a). Sections were incubated overnight at 4°C with primary antibody, in the presence of 1 % normal goat serum (NGS) and 0.1 % Nonidet P-40. After thorough washing to remove unbound primary antibody, sections incubated with SAi plus anti-TH or with SAi plus anti-SCGIO were developed using rhodamine-conjugated goat anti-rabbit IgG at 1:500 plus ftuorescein isothiocyanate (FITC)-conjugated goat anti-mouse lgG at 1:200 (TAGO, Inc., Burlingame, CA). Sections incubated with SAi plus B2 were developed using rhodarnine goat anti-mouse IgM (T AGO) and ATC-conjugated goat anti-mouse lgG (Southern Biotech, Inc., Atlanta, GA), both at 1:100. To reduce nonspecific binding, dilutions of secondary antibody were precleared by incubating for 1 hr at 4°C in 10% normal rat serum plus 5% NGS, and then centrifuged for 10 min at 14,000 x g. Controls lacking primary antibody exhibited no specific staining. Sections were mounted in para-phenylenediamine/glycerol and examined with an Olympus OMT-2 inverted microscope. All micrographs in this article illustrating SAl versus B2 staining were photographed and printed using identical exposure times, so that staining intensity is directly comparable among the figures. For the detection of phenylethanolamine N-methyl transferase (PNMT) immunoreactivity, a rabbit anti-PNMT antiserum (the generous gift of Dr. Martha Bohn, University of Rochester) was used at a dilution of I: 1000 and visualized using an FITC-conjugated goat anti-rabbit lgG secondary antibody (T AGO) at I :200. Isolation and culture of B2+ and B2-cells by FAGS. B2+ cells were isolated from dissociated suspensions of embryonic day 14.5 (El4.5) adrenal glands by surface labeling and fluorescence-activated cell sorting (FACS) as previously described (Anderson and Axel, 1986) . B2-cells were isolated using monoclonal antibody HNK-1 (Abo and Balch, 1981) , which labels all TH+ cells within the El4.5 adrenal gland (Anderson and Axel, 1986; Birren and Anderson, 1990) . We used HNK-1 rather than the SA(l,2,4) cocktail (Carnahan and Patterson, 1991b) to isolate B2-progenitors, because the SA antigens are poorly expressed on the cell surface in E14.5 adrenal suspensions (J. F. Carnahan, unpublished observations). As all B2+ cells are also HNK-1 +, however, in order to isolate the B2-fraction the B2+ cells first had to be eliminated by complement lysis using monoclonal antibody B2. The remaining B2-cells were then labeled with HNK-1 ascites diluted 1:500 and FITCconjugated goat anti-mouse lgM (TAGO). Virtually all HNK-1 +, B2-cells are TH+, and over 80% are SAi +,indicating that HNK-1 (in combination with B2 elimination) is a sympathoadrenal lineage surface marker comparable to the SA antibodies, for the E14.5 adrenal gland. B2+ and HNK-1+ (B2-) cells were separated from unlabeled cells by FACS using an Ortho instrument (Becton-Dickinson, Inc., Mountainview, CA) . Approximately 1-2% of the input cells were B2+, while 6-7% were B2-, HNK-1 +. Cells were cultured on a collagen/poly-o-lysine/ laminin substratum in steroid-stripped L-15-C0 2 complete medium as previously described (Anderson and Axel, 1986) , except that fetal calf serum was substituted for rat serum. When included, dexamethasone (DEX) was diluted from a stock solution of 10-3 M in 95% ethanol, to a final concentration of 1 µM. For quantifying the inhibition of process outgrowth, a cell cluster was defined as "process bearing" if any cytoplasmic extension could be detected originating from the cluster. It was not possible to determine whether every cell in a cluster was process bearing, because the tight clumping of the cells precluded assignment of processes to individual cells. Nonetheless, for the purposes of this study this measurement represents a highly stringent criterion, in that only clusters containing exclusively rounded cells were counted as nonprocess bearing. Any systematic error introduced by this method would, if anything, underestimate the difference in process outgrowth between B2-and B2+ cells. For single-cell tracking experiments, cells were identified 24 hr after plating and their positions marked by means of a gridded coordinate system embossed in the bottom of the dish using a BB press. Cells were photographed at that time and every 24 hr thereafter for the next 2 d.
Results

Transient coexpression of neuronal-and chromaffin-specific markers by cells in embryonic sympathetic ganglia
In the postnatal rat, the SAl-5 series of monoclonal antibodies specifically labels adrenal chromaffin cells but not sympathetic neurons (Carnahan and Patterson, 1991a) . In developing embryos, however, expression of the SAI antigen is detectable in cells of the primordial sympathetic ganglia, beginning at El 1.5 ( Fig. IA; see also Carnahan and Patterson, 199 la) . At this time, neural crest cells have aggregated in clusters adjacent to the dorsal aorta and can be recognized by their expression of TH, a lineage marker for adrenergic neural crest derivatives (Cochard et al., 1979) . Double labeling indicates that all SAl +cells appear to coexpress TH, and vice versa (Fig. lB) . No expression of SA 1 can be detected in premigratory or in migrating neural crest cells 1 d earlier in development (data not shown).
The initial expression ofSAl coincides not only with that of TH, but also with that ofneural-specific markers such as SCG 10
The Journal of Neuroscience, November 1991, 11 (11) 3509 (Anderson and Axel, 1985; Stein et al., 1988b) and NF68 (Cochard and Paulin, 1984) . To determine whether such neuronal markers are coexpressed in the same cells that express SAl, double-label immunohistochemistry was performed using a rabbit anti-SCG 10 antibody (Stein et al., l 988b) , mouse monoclonal SAI antibody, and species-specific secondary antibodies. Within the ganglionic cluster, SCG 10 ( Fig. ID) is expressed in an overall pattern that is coextensive with that of SA 1 (Fig. 1 C) . At higher magnification (Fig. 1E,F) , individual cells labeled by both anti-SCG 10 and SA 1 are visible; many of these cells are process bearing (Fig. lE,F, arrows) . It is difficult to determine whether all SA!+ cells are also SCGlO+, however, because the SCGlO antigen is membrane bound (Stein et al., 1988b) and concentrated in the perinuclear region (Fig. lD, arrow) whereas the SAI antigen exhibits a punctate, cytoplasmic distribution (Fig. IC, arrowhead) . Nevertheless, a substantial number of double-positive cells can be observed. For technical reasons, double labeling with monoclonal SAl and NF68 antibodies was not possible. However, the timing of TH and NF68 appearance is coincident (Cochard et al., 1979; Cochard and Paulin, 1984) , and TH and NF68 are coexpressed in SA precursors (Anderson and Axel, 1986) . It is therefore likely that SAl +ganglionic cells coexpress NF68 as well as SCG 10.
The coexpression of SA I, TH, and SCG 10 in individual ganglionic cells persists through E 12. 5 ( Fig. 2A-D) . After this time, the expression of SA 1 in the sympathetic ganglia begins to decline (see also Carnahan and Patterson, 199 la) . However, expression of SCG 10, TH, and NF is maintained, as previously described (Cochard et al., 1979; Cochard and Paulin, 1984; Anderson and Axel, 1986) .
Cells in sympathetic ganglia begin to express B2 coincident with the loss of SAJ
Previously, monoclonal antibody B2 (J. Dodd, unpublished observations) was shown to label specifically a population of neuronal precursors in El 4.5 sympathetic ganglia, as well as a subset of cells within the adrenal gland (Anderson and Axel, 1986) . As B2, like the SA antibodies, appears to be highly specific for cells of the SA lineage, it was of interest to determine the relative timing of expression of these two markers. In contrast to SA l, no staining with B2 can be detected in sympathetic ganglia, or elsewhere in the embryo, at El 1.5 (not shown). At El2.5, faint patches of punctate B2 staining can occasionally be seen (Fig.  2F ). These patches overlap some of the SAl + cells (Fig. 2E ). Over the next few days of development (E13.5-15.5), the intensity of B2 expression in the sympathetic ganglia increases, while that of SAl decreases (compare exposure-matched Figs. 2F, 3B, 4B), until SAl expression appears completely replaced by that of B2.
The increase in B2 expression appears to occur in a rostrocaudal gradient, with more anteriorly located ganglia ( Fig. 3B ) expressing higher levels than those located more posteriorly (Fig.  3D ). SAl staining does not appear to fade in a complementary rostrocaudal manner, however (Fig. 3A,C) . Within "transitional" sympathetic ganglia at El4.5, a complementary pattern of SA l and B2 expression is seen: regions of a given ganglion that are high in SAl (Fig. 4A , arrow) are low in B2 (Fig. 4B, arrow) ; conversely, regions that are high in B2 are low in SAl (Fig.  4A,B) . However, the overall domains ofSAl and B2 expression in such ganglia appear roughly coextensive. By El5.5-16.5, however, virtually all detectable SAi staining has disappeared, and the ganglia are uniformly strongly B2+. Taken together, these data indicate that expression ofB2 occurs subsequent to that of SA 1 during SA development but that there is a period of transient overlap between these two markers.
The SAJ--+ B2 transition does not occur in the adrenal medulla
Chromaffin cells derive from SA progenitors that continue migrating from the vicinity of the sympathetic ganglia to invade the adrenal gland primordium. This invasion begins between E 13.5 and El 4.5 (Bohn et al., 1981; Teitelman et al., 1982) . These invading progenitors express SA 1 (not shown). In contrast to their counterparts in the sympathetic ganglia, however, they appear for the most part to maintain expression of this antigen after settling within the adrenal (Fig. 4C ). For example, at El 4.5, many cells expressing high levels of SA 1 can be observed deep within the adrenal gland ( Fig. 4C,E ; arrowhead), whereas in the adjacent sympathetic ganglion virtually no SAi staining is detectable (Fig. 4C, arrow) . Conversely, the sympathetic ganglia · exhibit a high level of B2 labeling (Fig. 4D, arrow) , whereas only faint B2 staining is detected within the adrenal gland. In some sections, areas of intense B2 staining could be observed within the adrenal primordium (Fig. 4F, arrowhead) . However, these regions correspond to the future extraadrenal ganglionic complex (EAGC) (Lempinen, 1964) , a structure that segregates from the adrenal gland proper and eventually degenerates toward the end of gestation (Aloe and Levi-Montalcini, 1979) . Cells classified as "chromaffin cells" by histochemical stains have been identified in the embryo in locations outside of the adrenal gland (Lempinen, 1964 cells" also appear to undergo the SA I -B2 transition, like the cells in the sympathetic ganglia but unlike those within the adrenal gland (Fig. 5 ). For example, clusters of cells expressing SAi can be observed in the paraaortic region (Fig. 5A, arrows) at E14.5. Patches ofB2• cells are present in some, but not all, of these SA 1 • paraaortic clusters (Fig. 5B, arrows) . At higher magnification, the domains of B2 and SA l staining appear to be partially overlapping ( Fig. 5C,D; arrow), similar to the patterns in the transitional sympathetic ganglia (see above).
The appearance of B2 correlates with a loss of competence for chromaffin differentiation
The foregoing data indicated that neuroblasts in the sympathetic ganglia undergo a developmental change beginning on E13.5, in which they gradually extinguish expression of SA l and acquire expression ofB2. By contrast, this change does not appear to occur for the majority of cells that migrate to the adrenal gland. In order to determine whether this change in antigenic phenotype reflects changes in the developmental properties of sympathoadrenal progenitors, we studied in culture the behavior of B2+ and B2-cell populations isolated from El4.5 adrenal glands. The adrenal gland was chosen for this experiment because previous studies had indicated that, in addition to the majority B2-chromaffin precursor population, a subset of 82+ cells is present (Anderson and Axel, 1986 ; see also Fig. 4F) ; thus, both populations can be obtained from the same tissue. After isolating the B2+ cells, the B2-, TH+ cells were separated from non-SA lineage B2-cells using monoclonal antibody HNK-l (see Materials and Methods). This antibody identifies SA lineage cells in the adrenal gland, since all HNK-1 .. cells are also TH+ (Birren and Anderson, 1990 81 % ofB2+ cell clusters were process bearing, whereas only 4 7% of the B2-clusters bore neurites (Fig. 6A, NO ADD) . In addition, the processes on B2• cells tended to be longer, on average, than those on B2-cells (Anderson, 1988) . By day 3, however, 76% of cell clusters in the B2-population had extended processes (data not shown), indicating that most if not all of these cells are neuronal precursors but that their differentiation lags behind that of the B2• cells. The two cell populations also differed significantly in their ability to differentiate into chromaffin cells, as assessed by morphology and antigenic phenotype, in response to the synthetic glucocorticoid DEX. For example, after 24 hr of culture in 1 µM DEX, the majority of B2-cell clusters exhibited a round, chromaflin morphology; only 13% were process bearing (Fig.  6A, DEX, B2-) . By contrast, under these same conditions, over 60% of the B2• cells bore neurites (Fig. 6A, DEX, B2•) . Thus, DEX inhibited process outgrowth 72% in the B2-population, but only 24% in the B2• population. Cbromaffin differentiation was also assessed by staining cells with antibodies to the chromaffin-specific marker enzyme PNMT. After 3 d of culture in DEX, over 80% of the B2-cells exhibited PNMT immunoreactivity, whereas less than 50% of the 82+ cells expressed PNMT (Fig. 6B) . Taken together, these data indicate that the B2-population is less advanced in neuronal differentiation, and has a greater capacity for chromaffin differentiation, than the B2• population.
SA-1
Although the B2+ population on average is more advanced in neuronal differentiation than the 82-population, at the single cell level it is heterogeneous. Previous studies indicated that many B2• cells continue to extend neurites and then die in glucocorticoid but that a subset of cells can undergo chromaffin differentiation (Anderson and Axel, 1986) . Serial observations of identified cells now indicate that these two subpopulations can be identified prospectively by their different morphologies.
B2
The Journal of Neuroscience, November 1991. 11(11) 3513 We followed the fates of 72 individual B2+ cells in low-density cultures with DEX, over a 3 d period. Forty-three of these cells were initially process bearing; of those, 86% died over the ensuing culture period (Fig. 7, arrow) . The process-bearing cells that survived did not express detectable PNMT (not shown). On the other hand, of the 19 cells that survived and displayed a chromaffi.n phenotype, 84% derived from precursors initially lacking processes (Fig. 7, arrowhead) . (The remaining 16% de- rived from cells initially bearing short processes.) These data indicate a strong correlation between the initial morphology of B2+ cells and their response to glucocorticoid: cells with short processes or a round morphology are likely to survive and differentiate into chromaffin cells, whereas process-bearing cells are likely to continue to extend neurites and then die. The response of SA precursors to glucocorticoid can therefore be predicted based upon a combination of cell morphology and antigenic phenotype.
Expression of SAJ and B2 in late gestational embryos
The preceding observations revealed a good correlation between the position of SA lineage cells in the embryo and their antigenic phenotype, around £14.5-15.5. Cells that migrate to the adrenal gland maintain expression of SA I and do not induce B2, whereas cells that migrate to the sympathetic ganglia extinguish expression of SA I and induce B2. At later stages of gestation, however (ca. EI S.5), some violations of this "rule" were observed. For example, scattered patches of B2+ cells can be observed deep within the adrenal medulla (Fig. SB) . Conversely, patches of SAi + cells can be observed outside of the adrenal microenvironment, in the EAGC (Fig. SC) . The EAGC also contains patches of brightly stained B2+ cells (Fig. SD, arrow) . However, these patches exhibit a complementary, nonoverlapping distribution relative to the patches of SA 1 +cells ( Fig. SD, arrowheads; compare to 8C). Thus, the mutual exclusivity of high B2 and high SAi labeling persists, despite the fact that some cells of each phenotype appear in the "inappropriate" location. The SAi +and B2+ patches can also be distinguished by their relative levels of TH expression: SAi + patches are intensely stained with anti-TH antibody (Fig. 8£,F) , whereas B2+ patches are more weakly stained (not shown). B2+ patches, conversely, stain more intensely than SA l + patches with neuronal markers such as SCG 10 and NF68 (not shown). This pattern of marker expression supports the idea that the B2+ patches contain cells with a more neuronal phenotype than the SA I+ patches.
Discussion
Evidence for a bipotential SA progenitor in vivo Neural crest cells in the ventrolateral migration pathway make a late developmental decision between the expression of an endocrine or a neuronal phenotype. In vitro studies (Doupe et al., l 985b; Anderson and Axel, 1986; Seidl and Unsicker, I 989b; Carnahan and Patterson, 1991 b) have provided evidence that this decision is made by a progenitor cell whose choice of cell fate is determined, at least in part, by environmental factors. However, it has been difficult to verify this lineage relationship in vivo, because of the difficulties involved in tracing the fates of migratory cells in the mammalian embryo. In this study, we report the observation that at least some cells in embryonic sympathetic ganglia transiently coexpress neural-specific and chromaffin-specific markers. Cells that remain in the ganglion primordia lose expression of the chromaffin markers (SAl-5) and retain expression of the neuronal markers. Conversely, cells that migrate to the adrenal primordium lose expression of the neuronal markers (Anderson and Axel, 1986; Vogel and Weston, 1990 ) and retain expression ofSAI-5. These data are consistent with the idea that the transiently dual-phenotype cells are bipotential progenitors of chromaffin cells and sympathetic neurons, which selectively repress expression of the neuronal or chromaffin markers according to their final choice of cell fate.
An alternative explanation is that the disappearance of SA l immunoreactivity from the ganglion primordium at El4.5 is due to the death or emigration of SA I+ cells. This seems unlikely, because initially the SAi +cells are also TH+ and SCGlO+, and cells with a TH+, SCG 10+ phenotype remain in the ganglia even as SAi disappears. Moreover, we observe the concomitant appearance of a second marker, B2, in cells that are still weakly SAi +(see below). Thus, the cells that are initially SAi +appear to remain in the ganglion primordium and to change their antigenic phenotype, rather than to disappear. Furthermore, the isolation of SA I+ cells from E 13. 5 sympathetic ganglia has revealed that 90% of these cells initially express neurofilament 140 kDa and that these cells have the capacity to develop either into chromaffin cells or sympathetic neurons, depending upon culture conditions (Carnahan and Patterson, 1991 b) . Taken together, these data indicate that the SAi + , SCGlQ+ cells observed in embryonic sympathetic ganglia are likely to be precursors of sympathetic neurons in vivo.
The phenomenon of transient marker coexpression followed by mutually exclusive segregation is reminiscent of several other cell lineages, wherein bi-or multipotential progenitors have been shown to give rise to closely related but distinct cell types. In the immune system, for example, CD4+ and CD8+ peripheral T-lymphocytes have been shown to derive from a progenitor that is initially double positive for both of these cell-surface markers (Carbone et al., 1988; Fowlkes et al., 1988) . In the pituitary gland, somatotrophs expressing growth hormone and lactotrophs expressing prolactin are thought to develop from precursors that transiently coexpress both hormones (Hoeffter et al., 1985) . Finally, in the endocrine pancreas, embryonic islet progenitor cells have been shown to initially coexpress peptides, such as insulin and glucagon, which later segregate to different subpopulations of mature endocrine cells (Alpert et al., 1988) .
This phenomenon could reflect the fact that the coexpressed genes are regulated, in part, by transcription factors that are common to all cells of a given lineage (Bodner et al., 1988; Ingraham et al., 1988) . The later restriction of these markers to different subtypes of cells within the lineage could reflect the superposition of additional regulatory mechanisms, which finetune the pattern of gene expression. In the SA lineage, for example, the expression of neuronal markers such as SCG 10 can be upregulated by fibroblast growth factor (FGF) and NGF (factors which promote neuronal differentiation) and downregulated by glucocorticoid (which promotes chromaffin differentiation) (Stein et al., l 988a) . Conversely, chromaffin-abundant markers such as TH (Fig. 8£,F) are upregulated by glucocorticoid and downregulated by NGF (Leonard et al., 1987; Stein et al., l 988a) . In this way, a repertoire of lineage-specific gene expression established in progenitor cells by a common transcriptional program may be fine-tuned by differences in local environment, generating further phenotypic diversification.
Developing sympathetic neuroblasts undergo a switch in antigenic phenotype
Our antibody markers revealed a relatively late developmental event in the differentiation of sympathetic ganglionic neuroblasts: as expression of the SAi antigen declines, the cells induce the expression of a surface antigen recognized by monoclonal antibody B2. At intermediate times, both SAi and B2 are expressed in the same ganglia, and the pattern of expression of these two markers appears coextensive. Eventually, SAi expression becomes undetectable and the cells in the ganglia uniformly express high levels of B2. This pattern strongly suggests that the SA 1-+ B2 transition reflects a change in marker ex pres--+ The Journal of Neuroscience, November 1991, 11 (11) 3515 division followed by cell death. At 72 hr, only a single pycnotic figure is visible (arrow) . The arrowhead indicates an example of a non-processbearing cell (or cell cluster) that survived and displayed a rounded chromaffin morphology. Antibody staining indicated that cells of this phenotype were PNMT• (not shown). Note that process-bearing cells were also observed to die in cultures lacking DEX (not shown), indicating that the death of these cells is not caused by glucocorticoid. The extent of cell death is greater in the low-density cultures used in these single-cell tracking experiments than in the mass cultures used in population experiments; therefore, the results of the two types of experiments are not quantitatively comparable. (Carnahan and Patterson, 1991 b) , whereas cells isolated by sorting with B2 tend to extend processes shortly after plating (Anderson, 1988) . Moreover, most B2-, SAi • cells can be induced to differentiate into chromaffin cells at high frequency by glucocorticoid (see also Carnahan and Patterson, 1991 b ) . By contrast, process-bearing B2• ceUs are refractory to such an induction. As demonstrated previously (Anderson and Axel, 1986) , a minority ofB2+ cells remain responsive to glucocorticoid, but most of these cells initially exhibit a rounded morphology. The developmental heterogeneity within the adrenal B2+ population is consistent with the fact that 19% of freshly isolated B2+ cells express SA 1. T his could reflect the gradual nature of the SAi .... B2 transition, as suggested by the overlapping expression of SA I and B2 in sections of El4.5 sympathetic ganglia. Nevertheless, cells with a B2+, SAI -antigenic phenotype and a process-bearing morphology have lost competence to respond to glucocorticoid and appear committed to neuronal differentiation (Fig. 9) . The loss of responsiveness to glucocorticoid may serve to "insulate" immature sympathetic neurons from the steep rise in circulating fetal corticosterone levels, which begins on El6.5 (Teitelman et al., 1982) . Loss of competence is thought to be a feature of inductive processes in other embryonic systems (Gurdon, 1987; Grainger and Gurdon, 1989) .
Control of the SA J .... B2 transition
Cells that arrest migration in the sympathetic ganglia extinguish SA I and induce B2, whereas those t hat migrate into the adrenal primordium mostly fail to make this switch. Instead, chromaffin cells maintain expression of SAi into adulthood. This observation suggests that the SAI -B2 switch may be controlled by factors in the microenvironments encountered by SA progenitors. SA antigen-positive progenitors from sympathetic ganglia reduce levels of SAi expression in the absence of DEX but maintain expression in the presence of DEX (Carnahan and Patterson, 199 1 b) . Moreover, chromaffin cells from neonatal rats lose SA staining in the presence of NGF and absence of glucocorticoid (Carnahan and Patterson, 199 Ia) . These in vitro results suggest that in vivo, progenj tors within the adrenal prim ordium may be prevented from undergoing the SA l -B2 transition by the high local concentration of adrenal corticosteroids. The SA 1-B2 transition may also be promoted by factors that stimulate neuronal differentiation, such as FGF and NGF (Stemple et al., 1988; Birren and Anderson, 1990; Carnahan and Patterson, 199lb) .
The maintenance of SAl and fai lure to induce B2 are first apparent in the adrenal gland as early as El 4.5 (Fig. 4) , suggesting that glucocorticoids and their receptor are functional at this early stage. mRNA encoding the glucocorticoid receptor has been detected in the adrenal gland as early as El 5.5 (Anderson and Michelsohn, 1989) . However, using a radioligand binding assay, Seidl and Unsicker ( l 989b) have reported that glucocorticoid receptor is undetectable in adrenal medullary precursors prior to E 16.5. The reason for this apparent discrepancy is not clear. Chromaffin precursors may contain a low level ofreceptor that is sufficien t to mediate the inhibition ofneuronal d ifferentiation; alternatively, the SA 1-B2 transition may be suppressed in the early adrenal gland by factors other than steroid hormones. However, recent radioimmunoassay data indicate that the El 4.5 adrenal gland contains micromolar quantities of glucocorticoid (A. Michelsohn and 0 . J. Anderson, unpublished observations) . Whatever the case, the SA 1 and B2 markers provide evidence that progenitors in the adrenal gland are phenotypically distinct from their ganglionic counterparts 2 d before they express PNMT, the only other marker previously able to distinguish chromaffin cells from sympathetic neurons (Bohn et al., 1981; Teitelman et a l., 1982) .
The correlation between the antigenic phenotype of SA pro- Figure 9 . Schematic diagram illustrating sequence of antigenic changes in the SA lineage. The earliest bipotential progenitors are SA I• and B2-. They coexpress neuron-specific markers such as SCG 10 and chromaffin-specific markers such as SA 1-5, as illustrated by the crosshatching. In this study, progenitor celJs were isolated from El4.5 adrenal glands using monoclonal antibody HNK-1 in combination with 82-mediated complement lysis. Most but not all of these cells are also SA I •; those cells lacking SAi may have initiated neuronal differentiation. ln the absence ofg)ucocorticoids, these progenitors differentiate along the neuronal pathway, a process promoted by FGF and perhaps other, as yet unidentified factors. Cells that are B2• and SA 1-and that bear processes have lost competence to respond to glucocorticoid (com milled neuroblast). For clarity, intermediate stages of development between tile bipotential progenitor and committed neuroblast are omitted.
genitors and their location in the embryo is not perfect: occasional clusters ofB2• cells can be found within the adrenal gland, and clusters of SA I• cells are found outside ofit, late in gestation. T he B2• clusters probably correspond to clusters of Neuropeptide Y• cells observed by Henion and Landis (1990) . Similar clusters of cells with a neuronal phenotype have been found within the human feta l adrenal gland as well (Cooper et al., 1990) . Our in vitro results provide a possible explanation for this phenomenon: these 8 2+ neuronal cells derive from precursors that have lost competence to respond to glucocorticoid, either prior to or shortly after migration to the adrenal primordium. The majority of these cells disappear by the first postnatal week, probably being eliminated by cell death (Henion and Landis, 1989) . By the same token, at E 18.5 some SA l + cells can be found outside of the adrenal environment. Since the SA I~ B2 switch appears to occur slowly and asynchronously, these cells may have failed to induce 82 by El 6.5 and then have been prevented from doing so subsequently by the surge in fetal GC levels that occurs on E16.5-17.5 (Teitelman et al., 1982) . The decision to retain the SAl antigen may, moreover, become stabilized with further chromaffin development. Interestingly, the SAl • cells in the paraaortic and extraadrenal region are found in clusters, as are the B2+ cells. This suggests that once cells decide whether or not to make the SAl _, B2 switch, they may reinforce their immediate neighbors to do likewise. Such a "community effect" has been demonstrated for the process of mesodermal induction in Amphibia (Gurdon, 1988) . Alternatively, such clusters could reflect an aggregation (Henion and Landis, 1990) or clonal expansion of phenotypically similar cells.
Using a series of antibody markers, we have defined a sequence of events during the development of the SA lineage in the rat embryo (Fig. 9) . Bipotential SA progenitors initially coexpress both chromaffin-specific and neuron-specific markers and then differentiate into neurons or endocrine cells depending upon the environment to which they migrate. Subsequently, additional changes in marker expression are detected: cells in the sympathetic ganglia switch from an SAl + to a B2+ phenotype, whereas this switch fails to occur for the majority of cells within the adrenal gland. Studies of isolated SA progenitors in vitro indicate that this switch correlates with a loss of competence to respond to glucocorticoids, an inducing signal for chromaffin differentiation. Taken together, these data indicate that the development of sympathetic neurons and adrenal chromaffin cells is controlled not only by environmental signals, but also by changes in the ability of cells to respond to such signals. Such changes illustrate one way in which the developmental capacities of initially multipotent cells can become restricted during differentiation.
